Can a simple heart test after ablation prevent deadly rhythms?
NCT ID NCT06669299
First seen Mar 29, 2026 · Last updated Jun 04, 2026 · Updated 10 times
Summary
This study looks at whether a non-invasive heart stimulation test (NIPS) done a few days after a successful ablation can help doctors choose the best next step to prevent ventricular tachycardia from coming back. About 51 adults with an implanted defibrillator will be randomly assigned to either a repeat ablation or medication based on the test results. The goal is to see which approach better reduces the risk of the dangerous heart rhythm returning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA (VT) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
San Raffaele Hospital, Arrhythmology and Electrophysiology unit
RECRUITINGMilan, Italy, 20132, Italy
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.